NO20013154D0 - "Blood-pool"-midler for kjernemagnetisk resonans diagnostikk - Google Patents

"Blood-pool"-midler for kjernemagnetisk resonans diagnostikk

Info

Publication number
NO20013154D0
NO20013154D0 NO20013154A NO20013154A NO20013154D0 NO 20013154 D0 NO20013154 D0 NO 20013154D0 NO 20013154 A NO20013154 A NO 20013154A NO 20013154 A NO20013154 A NO 20013154A NO 20013154 D0 NO20013154 D0 NO 20013154D0
Authority
NO
Norway
Prior art keywords
pool
blood
agents
magnetic resonance
nuclear magnetic
Prior art date
Application number
NO20013154A
Other languages
English (en)
Other versions
NO322551B1 (no
NO20013154L (no
Inventor
Pier Lucio Anelli
Marino Brocchetta
Christoph De Haen
Ornella Gazzotti
Luciano Lattuada
Giovanna Lux
Giuseppe Manfredi
Pierfrancesco Morosini
Daniela Palano
Michele Serleti
Fulvio Uggeri
Massimo Visigalli
Original Assignee
Bracco Imaging Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Imaging Spa filed Critical Bracco Imaging Spa
Publication of NO20013154D0 publication Critical patent/NO20013154D0/no
Publication of NO20013154L publication Critical patent/NO20013154L/no
Publication of NO322551B1 publication Critical patent/NO322551B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y10S977/928—X-ray agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y10S977/929—Ultrasound contrast agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/927—Diagnostic contrast agent
    • Y10S977/93—MRI contrast agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20013154A 1998-12-23 2001-06-22 Anvendelse av gelaterte komplekser som "blood-pool"-midler for kjernemagnetisk resonansdiagnostikk NO322551B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998MI002802A IT1304501B1 (it) 1998-12-23 1998-12-23 Uso di derivati di acidi biliari coniugati con complessi metallicicome "blood pool agents" per l'indagine diagnostica tramite risonanza
PCT/EP1999/010002 WO2000038738A1 (en) 1998-12-23 1999-12-16 Blood pool agents for nuclear magnetic resonance diagnostics

Publications (3)

Publication Number Publication Date
NO20013154D0 true NO20013154D0 (no) 2001-06-22
NO20013154L NO20013154L (no) 2001-08-23
NO322551B1 NO322551B1 (no) 2006-10-23

Family

ID=11381326

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013154A NO322551B1 (no) 1998-12-23 2001-06-22 Anvendelse av gelaterte komplekser som "blood-pool"-midler for kjernemagnetisk resonansdiagnostikk

Country Status (20)

Country Link
US (1) US6461588B1 (no)
EP (2) EP1140209B1 (no)
JP (1) JP4733271B2 (no)
KR (1) KR100736298B1 (no)
CN (2) CN100450996C (no)
AT (1) ATE405296T1 (no)
AU (1) AU773876B2 (no)
CA (1) CA2355888C (no)
CZ (1) CZ302195B6 (no)
DE (1) DE69939398D1 (no)
HK (1) HK1042432B (no)
HU (1) HU228048B1 (no)
IL (2) IL143730A0 (no)
IT (1) IT1304501B1 (no)
MX (1) MXPA01006344A (no)
NO (1) NO322551B1 (no)
PL (1) PL196474B1 (no)
RU (2) RU2250765C2 (no)
WO (1) WO2000038738A1 (no)
ZA (1) ZA200104820B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW319763B (no) * 1995-02-01 1997-11-11 Epix Medical Inc
EP1019094B1 (en) 1997-10-02 2003-11-19 Epix Medical, Inc. Contrast-enhanced diagnostic imaging method for monitoring interventional therapies
IT1317862B1 (it) * 2000-02-29 2003-07-15 Bracco Spa Coniugati di acidi biliari con chelati complessi di ioni metallici eloro uso.
IT1318485B1 (it) * 2000-04-21 2003-08-25 Bracco Spa Uso di derivati di acidi biliari coniugati con complessi di ionimetallici nella visualizzazione diagnostica di sistemi microvascolari
US6900192B2 (en) * 2000-10-06 2005-05-31 Xenoport, Inc. Bile-acid conjugates for providing sustained systemic concentrations of drugs
EP1229041A1 (en) * 2001-02-05 2002-08-07 Bracco Imaging S.p.A. A process for the preparation of 3-Glutamido bile ester derivatives using N-tBoc methyl pyroglutamate
US7053076B2 (en) 2001-08-29 2006-05-30 Xenoport, Inc. Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
EP1302465A1 (en) 2001-10-11 2003-04-16 BRACCO IMAGING S.p.A. Enhanced substrate imaging by reversible binding to a paramagnetic complex
US7611692B2 (en) 2003-01-13 2009-11-03 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US8420050B2 (en) * 2003-01-13 2013-04-16 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7850947B2 (en) * 2003-01-13 2010-12-14 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
US7922998B2 (en) 2003-01-13 2011-04-12 Bracco Imaging S.P.A. Gastrin releasing peptide compounds
WO2004062574A2 (en) * 2003-01-13 2004-07-29 Bracco Imaging S.P.A. Improved linkers for radiopharmaceutical compounds
US7226577B2 (en) 2003-01-13 2007-06-05 Bracco Imaging, S. P. A. Gastrin releasing peptide compounds
RU2006126637A (ru) * 2003-12-24 2008-01-27 Бракко Имэджинг С.П.А. (It) Улучшенные производные пептида, высвобождающего гастрит
CN101827631B (zh) 2007-07-11 2013-04-24 得克萨斯系统大学董事会 用于成像中的粒子和标记物
CN101845112B (zh) * 2010-06-02 2011-09-14 华东理工大学 一种基于高分子纳米粒子的高灵敏性核磁共振成像造影剂的制备方法
AU2012207142B2 (en) * 2011-01-20 2017-04-27 Board Of Regents, The University Of Texas System MRI markers, delivery and extraction systems, and methods of manufacture and use thereof
EP2822605A1 (en) 2012-03-05 2015-01-14 Bracco Imaging S.p.A Dynamic contrast enhanced mri method and agents for the assessment of the macromolecular transport within pathologic tissues
CN102766188B (zh) * 2012-07-24 2016-01-13 上海交通大学 胆固醇衍生物、螯合物、重组高密度脂蛋白及其用途
GB201421163D0 (en) * 2014-11-28 2015-01-14 Ge Healthcare As Formulations of metal complexes
US10093741B1 (en) 2017-05-05 2018-10-09 Fusion Pharmaceuticals Inc. IGF-1R monoclonal antibodies and uses thereof
AU2018261890A1 (en) 2017-05-05 2019-11-28 Centre For Probe Development And Commercialization IGF-1R monoclonal antibodies and uses thereof
EP3619191A4 (en) 2017-05-05 2020-12-16 Fusion Pharmaceuticals Inc. PHARMACOKINETIC IMPROVEMENTS OF BIFUNCTIONAL CHELATES AND THEIR USES
US11547666B2 (en) * 2018-05-30 2023-01-10 Translate Bio, Inc. Cationic lipids comprising a steroidal moiety

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1213029B (it) * 1986-01-30 1989-12-07 Bracco Ind Chimica Spa Chelati di ioni metallici paramagnetici.
US5057302A (en) * 1987-02-13 1991-10-15 Abbott Laboratories Bifunctional chelating agents
US5227474A (en) * 1987-02-13 1993-07-13 Abbott Laboratories Bifunctional chelating agents
DE3930696A1 (de) * 1989-09-14 1991-03-28 Hoechst Ag Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel
NO940115D0 (no) * 1994-01-13 1994-01-13 Nycomed Imaging As Kontrastmidler for roentgen- og magnettomografisk avbildning
DE69534990T2 (de) * 1994-04-20 2006-10-05 Amersham Health Salutar Inc. Kontrastmittel
IT1269839B (it) * 1994-05-26 1997-04-15 Bracco Spa Coniugati di acidi biliari, loro derivati con complessi metallici e relativi usi
JPH11116542A (ja) * 1997-10-06 1999-04-27 Sogo Pharmaceut Co Ltd γ−グルタミン酸アミド類の製造法

Also Published As

Publication number Publication date
CN1333695A (zh) 2002-01-30
HUP0104715A3 (en) 2005-11-28
IT1304501B1 (it) 2001-03-19
CN1854122A (zh) 2006-11-01
EP1935435B1 (en) 2017-09-06
AU1980700A (en) 2000-07-31
ATE405296T1 (de) 2008-09-15
ZA200104820B (en) 2002-06-13
HUP0104715A2 (hu) 2002-04-29
EP1935435A3 (en) 2009-01-21
IL143730A0 (en) 2002-04-21
CZ302195B6 (cs) 2010-12-08
KR100736298B1 (ko) 2007-07-06
PL196474B1 (pl) 2008-01-31
US6461588B1 (en) 2002-10-08
JP4733271B2 (ja) 2011-07-27
HK1042432B (zh) 2007-01-26
HU228048B1 (en) 2012-09-28
RU2250765C2 (ru) 2005-04-27
CN1263515C (zh) 2006-07-12
KR20010099889A (ko) 2001-11-09
IL143730A (en) 2007-09-20
CZ20012330A3 (cs) 2002-01-16
RU2004127136A (ru) 2006-02-27
CN100450996C (zh) 2009-01-14
PL349488A1 (en) 2002-07-29
JP2002533420A (ja) 2002-10-08
NO322551B1 (no) 2006-10-23
DE69939398D1 (de) 2008-10-02
MXPA01006344A (es) 2002-06-04
CA2355888C (en) 2009-02-24
RU2395490C2 (ru) 2010-07-27
EP1935435A2 (en) 2008-06-25
EP1140209A1 (en) 2001-10-10
AU773876B2 (en) 2004-06-10
ITMI982802A1 (it) 2000-06-23
HK1042432A1 (en) 2002-08-16
EP1140209B1 (en) 2008-08-20
WO2000038738A1 (en) 2000-07-06
NO20013154L (no) 2001-08-23
CA2355888A1 (en) 2000-07-06

Similar Documents

Publication Publication Date Title
NO20013154L (no) "Blood-pool"-midler for kjernemagnetisk resonans diagnostikk
DE59105815D1 (de) 1,4,7,10-Tetraazacyclododecan-butyltriole, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel.
ES2087938T3 (es) Uso de complejos quelatos.
FI955319A (fi) 2-pyridyylimetyleenipolyatsamakrosyklofosfonihappoja, niiden komplekseja ja johdannaisia käytettäväksi vasta-aineina
WO1999064409A3 (de) Benzothiepin-1,1-dioxidderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
DK0560910T3 (da) I molekylsigte indesluttet paramagnetisk ion for diagnose
ATE294813T1 (de) Konjugate von gallensäure mit metallbindenden chelatverbdingungen und die verwendung davon
DE69131636T2 (de) (6,7-substituierte-8-Alkoxy-1-cyclopropyl-1,4-dihydro-4-oxo-3-chinolinkarbonsäure-03,04)-bis(acyloxy-0)-Borate und ihre Salze sowie Methoden zu ihrer Herstellung
CA2119345A1 (en) Methods for the In Vivo Measurement of the Concentration of NMR-Detectable Xenobiotic Compounds
CA2103554A1 (en) Bicyclopolyazamacrocyclocarboxylic acid complexes, their conjugates, processes for their preparation, and use as contrast agents
TR199701716T1 (xx) Poliaminoasitlerin metal kompleksleri.
ATE160943T1 (de) Bicycloazamakrocyclophosphon-säure, komplexe, konjugate, kontrastmittel und herstellung
DE69837219D1 (de) 1,4,7,10-tetraazacyclododecan-1,4-diessigsäure
WO1995022544A3 (de) Substituierte 1,3,8-triaza-spiro(4,5)-decan-4-on-derivate als vorstufen zur herstellung von pharmazeutika
IT1242026B (it) Composizione farmaceutica contenente un complesso ferro-schizokinene per il trattamento dell'anemia ferropenica.
ATE120751T1 (de) Phosphonsäurederivate als entzündungshemmende mittel.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees